Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.

Global Head, Health Services, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
Engagement Manager, Oliver Wyman

It's time to marry trust with data ownership.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

In the next decade, incumbents and innovators vying for a different relationship with consumers will shape healthcare’s front end.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

As featured in this year's Oliver Wyman Health Innovation Journal, we examine the emerging sparks beginning to define the dimensions of a new healthcare industry.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Why the healthcare industry incurs one of the highest financial costs in the face of a cyberattack. Are you prepared?

Partner, Strategy, IT & Operation, Oliver Wyman
Principal, Financial Services, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

How genetics can help cut treatment costs by getting prevention services to consumers most at risk.

Chief Operating Officer, Color Genomics, Inc

Why healthcare needs the new technology and how investors and innovators can take advantage of the revolution.

Chief Strategy Officer, BCBS of Massachusetts

As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More